Who can pay for innovative medicines?

Decramer Stefaan, Decramer Marc

Source: Eur Respir J 2013; 41: 495-496
Journal Issue: March

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Decramer Stefaan, Decramer Marc. Who can pay for innovative medicines?. Eur Respir J 2013; 41: 495-496

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Tele-medicine: a new promised land, just to save resources?
Source: Eur Respir J, 49 (5) 1700410; 10.1183/13993003.00410-2017
Year: 2017

Which equipment to choose?
Source: Annual Congress 2009 - PG16 How to organise a respiratory high dependency unit?
Year: 2009

Should we treat every patient with latent TB? Is there a cost to pay?
Source: International Congress 2018 – Tuberculosis transmission and screening strategies
Year: 2018

The sustainability agenda and inhaled therapy: what do patients want?
Source: Virtual Congress 2021 – Asthma inhalers: new devices and adherence
Year: 2021

What do scientists and doctors want from media coverage? How can patient input strengthen a news story?
Source: Annual Congress 2013 –ELF/ERS “Effective engagement of patients and the public in science, healthcare and the media”
Year: 2013

“Education is the passport to the future”: enabling today’s medical teachers to prepare tomorrow’s respiratory health practitioners
Source: Eur Respir J 2014; 44: 578-584
Year: 2014

Studying respiratory medicine collaboratively online -do medical students perceive it an effort worth pursuing?
Source: Annual Congress 2009 - E-learning in medical education
Year: 2009

In the era of personalized medicine, what are the current unmet needs in asthma?
Source: International Congress 2019 – The journey towards personalized medicine in asthma: where are we now?
Year: 2019

"Don’t get me wrong, I think case finding is okay" Exploring healthcare professionals’ perspectives on target case-finding for COPD
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016

Respiratory medicines for children: current evidence, unlicensed use and research priorities
Source: Eur Respir J 2010; 35: 247-265
Year: 2010

Tele-education in asthma management. What are the benefits?
Source: Annual Congress 2012 - Improving education for the healthcare team and patients
Year: 2012

Personalised medicine: how ready are we for this?
Source: Annual Congress 2013 –Ceremony for the ERS Maurizio Vignola Award for Best Publication on Innovation in Pneumology (financially supported by Chiesi Foundation) followed by Hot Topic: Towards delivering personalised or precision medicine in respiratory healthcare
Year: 2013

Getting approval for new therapeutic medical devices versus drugs: are the differences justified?
Source: Eur Respir Rev 2016; 25: 223-226
Year: 2016

Personalised medicine: are we ready?
Source: Eur Respir Rev, 26 (145) 170088; 10.1183/16000617.0088-2017
Year: 2017

Does an mHealth system reduce health service use for asthma?
Source: ERJ Open Res, 6 (3) 00340-2019; 10.1183/23120541.00340-2019
Year: 2020

Preventing skin care issues associated with face masks used for domiciliary non-invasive ventilation: what do users and their carers think are the most relevant future research questions?
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019

The issues and the controversies: are we really ready for on-demand use of ICS?
Source: Annual Congress 2013 –Inhaled corticosteroids for asthma: on-demand or continuous use?
Year: 2013